IN2014DN10134A - - Google Patents

Download PDF

Info

Publication number
IN2014DN10134A
IN2014DN10134A IN10134DEN2014A IN2014DN10134A IN 2014DN10134 A IN2014DN10134 A IN 2014DN10134A IN 10134DEN2014 A IN10134DEN2014 A IN 10134DEN2014A IN 2014DN10134 A IN2014DN10134 A IN 2014DN10134A
Authority
IN
India
Prior art keywords
vesicular
active agent
biologically active
formulation
administering
Prior art date
Application number
Other languages
English (en)
Inventor
Richard Wolf Garraway
John Mayo
William Henry
Original Assignee
Sequessome Technology Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sequessome Technology Holdings Ltd filed Critical Sequessome Technology Holdings Ltd
Publication of IN2014DN10134A publication Critical patent/IN2014DN10134A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/305—Mercury compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Cosmetics (AREA)
IN10134DEN2014 2012-05-14 2013-05-10 IN2014DN10134A (pm)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB201208384A GB201208384D0 (en) 2012-05-14 2012-05-14 Vesicular formulations, uses and methods
PCT/EP2013/059740 WO2013171131A1 (en) 2012-05-14 2013-05-10 Vesicular formulations, uses and methods

Publications (1)

Publication Number Publication Date
IN2014DN10134A true IN2014DN10134A (pm) 2015-08-21

Family

ID=46458741

Family Applications (1)

Application Number Title Priority Date Filing Date
IN10134DEN2014 IN2014DN10134A (pm) 2012-05-14 2013-05-10

Country Status (9)

Country Link
US (1) US20150125407A1 (pm)
EP (1) EP2849721A1 (pm)
JP (1) JP2015516453A (pm)
CN (1) CN104411298A (pm)
DE (1) DE112013002492T5 (pm)
GB (1) GB201208384D0 (pm)
HK (1) HK1209027A1 (pm)
IN (1) IN2014DN10134A (pm)
WO (1) WO2013171131A1 (pm)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2467170A4 (en) 2009-08-21 2013-05-29 Targeted Delivery Technologies Ltd vesicle
GB201205642D0 (en) 2012-03-29 2012-05-16 Sequessome Technology Holdings Ltd Vesicular formulations
CA3026466A1 (en) 2015-06-30 2017-01-05 Sequessome Technology Holdings Limited Blended formulations

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63501289A (ja) * 1985-09-27 1988-05-19 ザ　リ−ジエンツ　オブ　ザ　ユニバ−シテイ　オブ　カリフオルニア リポソ−ム経皮薬剤供給系
US6165500A (en) 1990-08-24 2000-12-26 Idea Ag Preparation for the application of agents in mini-droplets
JP3765579B2 (ja) 1990-08-24 2006-04-12 イーデーエーアー アーゲー 作用物質投与用超微小滴状調剤
JPH06293615A (ja) * 1992-08-25 1994-10-21 Nippon Oil & Fats Co Ltd 混合脂質膜小胞を含有する化粧品
US6113921A (en) * 1993-03-23 2000-09-05 Pharmos Corp. Topical and transdermal delivery system utilizing submicron oil spheres
US6294192B1 (en) 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US20040009180A1 (en) * 2002-07-11 2004-01-15 Allergan, Inc. Transdermal botulinum toxin compositions
US20040105881A1 (en) 2002-10-11 2004-06-03 Gregor Cevc Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
US20100150994A1 (en) * 2006-12-01 2010-06-17 Anterios, Inc. Amphiphilic entity nanoparticles
ES2335636B1 (es) * 2008-02-29 2011-05-11 Lipotec, S.A. Composicion cosmetica o dermofarmaceutica de micelas mixtas.
WO2010140061A2 (en) 2009-06-03 2010-12-09 John Charles Mayo Formulations for the treatment of deep tissue pain
EP2467170A4 (en) 2009-08-21 2013-05-29 Targeted Delivery Technologies Ltd vesicle

Also Published As

Publication number Publication date
GB201208384D0 (en) 2012-06-27
WO2013171131A1 (en) 2013-11-21
CN104411298A (zh) 2015-03-11
US20150125407A1 (en) 2015-05-07
JP2015516453A (ja) 2015-06-11
DE112013002492T5 (de) 2015-02-19
EP2849721A1 (en) 2015-03-25
HK1209027A1 (en) 2016-03-24

Similar Documents

Publication Publication Date Title
TN2012000611A1 (en) Formulations of rifaximin and uses thereof
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX348823B (es) Formulaciones estables de linaclotida.
MX388963B (es) Formulacion farmaceutica acuosa de tapentadol para administracion oral
NZ726488A (en) Compositions and methods for transmucosal absorption
MY173215A (en) Acetylcysteine compositions and methods of use thereof
TN2012000488A1 (en) Pharmaceutical compositions comprising hydromorphone and naloxone
MY165888A (en) Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation
GB2523707A (en) Novel pharmaceutical formulations and their use in the treatment of periodontal disease
NZ718163A (en) Extended-release formulation for reducing the frequency of urination and method of use thereof
MY173582A (en) Extended-release formulation for reducing the frequency of urination and method of use thereof
MX2013008175A (es) Composiciones farmacéuticas para suministro tópico de fotosensibilizadores y usos de los mismos.
PH12014502619A1 (en) Novel dosage and formulation
BR112015027436A2 (en) Topical composition and carrier for administration of pharmaceutically or cosmetically active ingredients
MX2014014579A (es) Composiciones farmaceuticas topicas de tipo emulsion aceite en agua que contienen un retinoide.
PH12016500142A1 (en) Vesicles
TR200806300A2 (tr) Çözünürlük artırıcı farmasötlk formulasyon
IN2014DN10134A (pm)
PH12015500070B1 (en) Pediatric oral liquid compositions containing nepadutant
IN2014CN04119A (pm)
EA201690113A1 (ru) Везикулы
TR200806299A2 (tr) Çözünürlük artırıcı farmasötik formülasyon
MY184940A (en) Lignosus rhinocerus (tiger-milk mushroom) as anti-inflammatory agent